Sign-up to receive the company presentation and be notified when the company goes public.
Complete the form below and receive more information about this exciting opportunity.
Become an Early Stage Investor
in the Next Big Biotech Trend
PreveCeutical Medical Inc. is a health and wellness company focused on "preveceuticals" - or pharmaceuticals designed to be preventive rather than reactive.
Capitalize on the Preventive Health Industry
The global preventive healthcare market is rapidly emerging as the most viable means to cut healthcare costs.
Transparency Market Research estimates that the market will grow at a 9.7% compound annual growth rate between 2014 and 2020 to US$144.8 billion. These technologies are focused on early detection and treatment of serious medical conditions that cost the healthcare industry trillions each year.
PreveCeutical Medical is focused on developing a combination of prescription and over-the-counter products designed to help individuals live a healthier life before they're afflicted with serious diseases. These products include its CELLB9(TM) oral solution containing essential minerals extracted from a novel peptide obtained from Blue Scorpion serum.
The company is conducting a 36-month pre-clinical evaluation program led by Chief Science Officer Dr. Makarand Jawadekar to develop an extensive patent portfolio and position specific synthesized peptides for IND and Phase I clinical trials in partnership with established pharmaceutical companies.
Profit & Enjoy
Know when the company is about to go public to get involved early.
Get access to the latest research and commentary about the firm.
Know that you've invested in the latest in healthcare technology.
Copyright © CFN Media 2017.